Do Post-Market Drug Trials Need a Higher Dose of Ethics?
The FDA, which requested the IOM begin its analysis in 2010, said in response to the report that it is "currently engaged
post market drug trials need high dose ethics fda req USA  iom begin analysis say response report currently engage